As there are few studies on these two aspects, this indicates that when there is a bottleneck in the studies of lipid metabolism, the effects of mTOR-based regulation of gut microbiota, genetic polymorphisms, and epigenetics on NAFLD can be considered from another perspective. This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.